What is CEHTRA?
• A consultancy specializing
in REACH
• A fast growing consulting company with 8 years of experience.
CEHTRA recruits its consultants on
the basis of their broad experience, curiosity, and enthusiasm to take
on a challenge. Of the 22 scientists currently employed, all are highly
qualified with over 50% holding a Ph.D or equivalent in toxicology,
an environmental science or in pharmacology/medicine. All others hold
at least a Masters degree. Together they have a sum total close to two
centuries of regulatory toxicology experience, specialising in European
risk assessment from related fields (Plant Protection products, biocides
and chemicals, both organic and inorganic).
How many companies
have faith in CETHRA?
• In just 8 years, 850
projects conducted through 75 000 hours of consulting for 160 different
clients including most of the largest chemical companies in the world.
What’s the glue that
makes us stronger?
• While the specific
details of risk assessment may vary from one regulatory field to another,
the skills required in all branches are the same: a broad understanding
of the inherent properties and complex processes that lead to fate and
toxicity of chemical substances. How better than to hone these skills
on some of the most challenging chemical substances in the world?
REACH
Currently CEHTRA
is on 40 REACH related projects:
• REACH compliance audit and
strategic advice for 15 companies
• Pre-registration dossiers
• IUCLID 5 dossiers for a wide range of substance (completed
or on-going) for a host of world class chemical manufacturers
• Complete registration dossiers for manufacturers including
petroleum based products (category approach)
• Participation in several SIEF’s/Consortia on behalf
of clients
• Consortium management for large consortia (>40 companies)
• CEHTRA is also one of the
promoters of LTS-REACH-OR SAS,
an Only Representative company. Through this activity several CEHTRA
scientists have also acquired a broad experience in pre-registration
and diverse and challenging REACH regulation issues and SIEF management.
|